Investor Relations
Advantages of the Only Cannabis Health Plan
Core Investment Drivers:
- Captive B2B Adoption: Directing policyholders to in-network dispensaries establishes our platform as a patient funnel for MSOs.
- Margin Insulation: Standardized health plan benefits shield the financial ecosystem from localized retail price wars.
- Predictable Cash Flow: Territory-based reimbursement guarantees stable, utilization-linked premium revenue.
Capital Structure
As of June 30, 2026
| Authorized Shares: | 200 million | |
| Outstanding Shares: | 128,803,624 | |
| Float: | 30,948,730 | |
| Par Value: | $0.001 | |
| Restricted Shares: | 88,989,251 | |
NDEV’s Debt Crisis Advantage
Cannabis INDUSTRY VULNERABILITY
- The $6 Billion Debt Crisis: The U.S. cannabis industry faces a severe financial bottleneck with expensive, hard-to-refinance debt coming due by the end of 2026.
- Dilution Threat: Inability to refinance on favorable terms will likely prompt lenders to convert debt into equity, forcing massive shareholder dilution across the sector.
NDEV Business Model Comparison
- Asset-Light Insurance: By operating strictly as a health insurance carrier and using an HMO-style business model, NDEV does not directly handle cannabis.
- Complete Insulation: This eliminates the need for extreme capital expenditures and protects shareholder equity.
Core Operational Infrastructure
The "Affordability Gap" & Schedule III Tailwinds
the DOJ.Schedule III reclassification eliminates federal 280E taxes for dispensaries, while NDEV provides up to 45% discounts and 15%–17% effective tax reductions to combat high state consumer excise taxes
Corporate & Personal HSA Integration
Employer-Sponsored Health Plans and Health Reimbursement Accounts directly fund policy premiums and medical reimbursements.
Dual-Platform Compliance Firewall
NDEV’s proprietary dual-platform framework that programmatically isolates the medical prescription drug plan operations from the physical cannabis distribution ordering platform.
How Reimbursement Works?
Reimbursement derives from policy revenue, contractually channeled to the MSO via standardized service fees. Defined exclusive territories secure asset utilization, protecting economic rights and ensuring stable, non-dilutable cash flow for MSO infrastructure.
Novus Acquisition & Development Corporation (NDEV), operating as Novus Cannabis MedPlan®, has pioneered health insurance that covers both THC/CBD cannabis and traditional prescription drugs since 2015. This proprietary dual-coverage structure provides a financial moat, ensuring stable, recurring revenue for Novus and its in-network providers.
Revenue is generated from insurance premiums, giving policyholders access to medications via an online distribution platform. NDEV has a national reach through 15,000 agents/brokers and over 200 dispensaries.
 | 6/3/2026 | |
| 5/14/2026 | |
| 3/3/2026 | |
| 12/17/2025 | |
| 11/12/2025 | |
| 10/07/2025 | |
| 08/12/2025 | |
| 07/08/2025 | |
| 05/12/2025 | |
| 03/23/2025 |
Cap Structure
As of June 30, 2026
| Authorized Shares: | 200 million | |
| Outstanding Shares: | 128,803,624 | |
| Float: | 30,948,730 | |
| Par Value: | $0.001 | |
| Restricted Shares: | 88,989,251 | |
Due Diligence Links
As of June 30, 2026
| Quote: | Click Here |
| Filings: | Click Here |
| Pitch Deck: | Click Here |
| Investment Highlights Video: | Click Here |
Footnotes:
- Leak Out Vendor Shares: Third-party vendors with treasury-issued stock must sell their shares gradually based on 15% of the average daily trading volume over the past 30 days.
- Insider Sales: No insider selling common stock for three years.
1. Compliance & The “Ancillary” Advantage
Novus is a non-plant-touching technology and administrative platform. Because we do not handle or profit directly from the sale of cannabis, we are not subject to IRS 280E tax restrictions. Our core product is a federally compliant Prescription Drug Program (PDP); cannabis is integrated strictly as a “value-added” discount feature, de-risking the model for institutional investors and traditional banking.
2. Employer-Centric Customization
We empower HR departments to modernize health benefits without legal exposure. Novus provides the framework for companies to align corporate values with modern wellness needs, offering a compliant structure that integrates cannabis-inclusive policies into traditional employer-sponsored health plans.
3. Novus Cannabis RX: Hybrid D2C Platform
Our Direct-to-Consumer platform bridges traditional healthcare and the cannabis industry through a “hybrid” model:
Traditional PDP: A robust prescription drug plan for FDA-approved medications.
Value-Added Access: Exclusive, pre-negotiated discounts at a nationwide network of licensed dispensaries.
Digital Integration: A single, professional portal for both traditional pharmacy benefits and alternative wellness.
4. Strategic Market Expansion
Novus is the primary “on-ramp” for consumers transitioning from the legacy (unregulated) market to legal, lab-tested products. By targeting the untapped employer market and partnering with national insurance brokers, the Novus MedPlan is positioned as the definitive distribution solution for the mainstreaming cannabis economy.
Federal Regulation: A Model Optimized for Growth
Strategic Positioning & Tax Efficiency: Novus is engineered to thrive within the current regulatory landscape. As a non-plant-touching technology and administrative platform, we are structurally insulated from the punitive restrictions that impact cultivators and retailers. This allows Novus to maintain standard corporate tax deductions and a healthy, scalable bottom line.
Institutional-Grade Compliance: We operate as a “grown-up” player in the space, prioritizing rigorous adherence to federal financial standards. Novus maintains strict Anti-Money Laundering (AML) and Bank Secrecy Act (BSA) protocols. This commitment to high-level compliance ensures we remain “institutional-ready,” safeguarding our relationships with traditional banking partners and enterprise-level clients.
Legislative Catalysts as Growth Drivers: Rather than remaining unaffected by federal shifts, Novus is positioned to catch the wave of industry evolution. We view Cannabis Rescheduling (Schedule III) and the SAFER Banking Act as massive growth tailwinds. These milestones will lower the barrier for entry for Fortune 500 employers, triggering a surge in demand for the compliant, turnkey benefit solutions that only Novus provides.
Interstate Scalability: By utilizing a state-regulated insurance framework and a federally compliant Prescription Drug Program (PDP), Novus can scale efficiently across legal jurisdictions. We provide a federally defensible bridge between traditional healthcare and the cannabis industry, offering stability in an evolving market.
Contact Us
* Indicates Required Field
855-228-7355
We are available Monday - Friday 9:00 am - 5:00 pm (EST) Email: info@getnovusnow.com
Forward-Looking Statements and Disclaimer: All communications, including AI-generated avatars accessed via social media, emails, SMS text messages, and other channels, are generated exclusively by Novus Acquisition & Development Corp (NDEV). NDEV does not utilize third-party agencies for press releases or promotional content. All materials rely solely on verified, publicly available investor relations data. The information provided is for informational purposes only and does not constitute investment or financial advice, nor is it an offer to sell or a solicitation of an offer to buy any securities.
